MoonLake Immunotherapeutics Dividend
Dividend criteria checks 0/6
MoonLake Immunotherapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.8% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$0.65 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Here's Why We're Not At All Concerned With MoonLake Immunotherapeutics' (NASDAQ:MLTX) Cash Burn Situation
May 14MoonLake Immunotherapeutics: Novel Technology, But Still In Phase 3
Feb 26We're Not Worried About MoonLake Immunotherapeutics' (NASDAQ:MLTX) Cash Burn
Jan 29Here's Why We're Not At All Concerned With MoonLake Immunotherapeutics' (NASDAQ:MLTX) Cash Burn Situation
Oct 16Vetter Pharma to provide fill and finish services to MoonLake Immunotherapeutics
Jul 26Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if MLTX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MLTX's dividend payments have been increasing.
Dividend Yield vs Market
MoonLake Immunotherapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (MLTX) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Biotechs) | 2.8% |
Analyst forecast in 3 Years (MLTX) | n/a |
Notable Dividend: Unable to evaluate MLTX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MLTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate MLTX's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as MLTX has not reported any payouts.